Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Denali Therapeutics
(4DN.F) Q2 2026
Earnings
4DN.F
May 7
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.69
-0.65
-0.62
-0.59
Details
Expected EPS
-0.61676264377
Actual EPS
-0.5883423
Surprise EPS
0.03
Surprise Percent
+4.61%
Description
Denali Therapeutics (4DN.F) has reported earnings of -0.5883423 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login